BC
ELV icon

Brahman Capital’s Elevance Health ELV Stock Holding History

Brahman Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$10.4M Buy
+23,782
New +$10.8M 3.77% 9

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brahman Capital's ELV Position: Q3 2023 in Review

Brahman Capital opened a new position in Elevance Health (ELV) in Q3 2023: 23,782 shares worth $10.4M. The stake represents 3.77% of the portfolio and ranks #9 among its holdings.

1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Brahman Capital held 23,782 shares of Elevance Health worth $10.4M as of Q3 2023.
  • Elevance Health was a new Brahman Capital position in Q3 2023.
  • Elevance Health made up 3.77% of Brahman Capital's portfolio in Q3 2023, its #9 holding.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Brahman Capital's 13F filing for Q3 2023, filed 14 Nov 2023.